Search Results - "Malysheva, A. M."

A Higher Level of Expression of the Nucleolar Protein SURF6 in Human Normal Activated Lymphocytes and in Lymphocytes of Patients with Lymphoproliferative Disorders by Moraleva, A. A., Malysheva, M. A., Khajdukov, S. V., Zatsepina, O. V.

“…Proliferation of mammalian cells is often accompanied by an increase in the content of the nucleolar proteins, which allows researchers to consider such…”
Get full text

Unmanned aerial vehicles: potential for use in the storage systems of industrial companies by Barkova, N. Yu, Deulina, E. D., Malysheva, M. A., Kirsanova, D. P., Borodina, O. A.

“…In the article, the authors investigate the problem of using unmanned aerial vehicles (drones) in company warehouses and consider their use as one of the ways…”
Get full text

Adhesive Compounds Based on Chlorinated Polyisoprenes by Malysheva, M. A., Lyusova, L. R., Zuev, A. A., Bryk, Ya. A., Chaikun, A. M.

“…Adhesive compounds based on chlorinated natural rubber of foreign (Pergut S20) and domestic chlorinated polyisoprene (Cl-SKI-3 and Cl-SKI-5) production are…”
Get full text

VALUE OF SPECIFIC PARAMETERS AND INTEGRATIVE INDICES OF TREADMILL TEST FOR THE ASSESSMENT OF CORONARY STENOSIS SEVERITY by Martsevich, S. Yu, Tolpygina, S. N., Malysheva, A. M., Polyanskaya, Yu. N., Gofman, E. A., Lerman, O. V., Mazaev, V. P., Deev, A. D.

“…Aim. To assess the value of specific parameters and integrated indices (II; such as Duke Index (DI), Centre for Preventive Medicine Index (CPMI), and modified…”
Get full text

DEVELOPING A REGISTER OF OUTCOMES OF CHRONIC CORONARY HEART DISEASE: CHD PROGNOSIS STUDY by Tolpygina, S. N., Martsevich, S. Yu, Gofman, E. A., Malysheva, A. M., Polyanskaya, Yu. N., Deev, A. D.

“…Aim. Using the data from the CHD PROGNOSIS register, to assess the long-term survival of patients with stable coronary heart disease (CHD) confirmed by a…”
Get full text

Role of selected parameters and integral indices of treadmill test in the assessment of complication risk among patients with chronic coronary heart disease by Martsevich, S. Yu, Tolpygina, S. N., Malysheva, A. M., Polyanskaya, Yu. N., Hofmann, E. A., Lerman, O. V., Mazaev, V. P., Deev, A. D.

“…Aim. To identify the value of selected parameters and integral indices of treadmill test (TT), such as Duke Treadmill Score (DTS), Centre for Preventive…”
Get full text

MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE by Martsevich, S. Yu, Ginzburg, M. L., Malysheva, A. M., Polyanskaya, Yu. N., Kheliya, T. G., Kutishenko, N. P.

“…Aim. To study a rate of clopidogrel use in patients having indications for clopidogrel therapy according with up to date guidelines. Material and methods…”
Get full text

Activity of nucleolar organizers in hepatocytes of rats with cirrhosis of the liver after treatment with bioactive preparations by Malysheva, A M, Popkov, P N, Kurenkov, E L, Ryabinin, V E, Grobovoi, S I

“…The therapeutic efficiency of bioactive preparations of the liver and spleen in the treatment of experimental toxic cirrhosis of the liver is shown. Evaluation…”
Get full text

ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE by S. Yu. Martsevich, N. P. Kutishenko, M. L. Ginzburg, A. M. Malysheva, Yu. N. Polyanskaya

“…Evidence based medicine data on ability of antiplatelet, including dual antiplatelet, therapy to improve the life expectancy of patients with high risk of…”
Get full text

ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE by S. Yu. Martsevich, N. P. Kutishenko, M. L. Ginzburg, A. M. Malysheva, Yu. N. Polyanskaya

“…Evidence based medicine data on ability of antiplatelet, including dual antiplatelet, therapy to improve the life expectancy of patients with high risk of…”
Get full text

Cardioprotective characteristics of the drug nicorandil in patients with coronary heart disease by Malysheva, A M, Martsevich, S Iu, Ginzburg, M L

“…Nicorandil, opener of potassium channels, was studied in Russia and abroad. Its cardioprotective, anti-ischemic, pharmacokinetic and pharmacodynamic properties…”
Get more information

UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE by S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev

“…Aim. To assess the real rate of dual antiplatelet therapy (DAT, acetylsalicylic acid + clopidogrel) use in patients having appropriate indications according to…”
Get full text

UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE by S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev

“…Aim. To assess the real rate of dual antiplatelet therapy (DAT, acetylsalicylic acid + clopidogrel) use in patients having appropriate indications according to…”
Get full text

FIRST RESULTS OF CHD PROGNOSIS STUDY by E. A. Gofman, S. Yu. Martsevich, A. D. Deev, A. M. Malysheva, Yu. N. Polyanskaya, S. N. Tolpygina, V. P. Mazaev

“…Aim — to investigate the prognostic value of different risk factors associated with stable angina in a contemporary population of patients, to identify the key…”
Get full text

Acardioprotective drug nikorandil in coronary heart disease by Anna Mikhaylovna Malysheva, Sergey Yur'evich Martsevich, Moisey L'vovich Ginzburg, A M Malysheva, S Yu Martsevich, M L Ginzburg

“…Nicorandil, opener of potassium channels, was studied in Russia and abroad. Its cardioprotective, anti-ischemic, pharmacokinetic and pharmacodynamic properties…”
Get full text

UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE by Martsevich, S. Yu, Voronina, V. P., Ginzburg, M. L., Kutishenko, N. P., Polyanskaya, Yu. N., Kheliya, T. G., Malysheva, A. M., Tolpygina, S. N., Kutuzova, V. S., Gofman, E. A., Deev, A. D.

Get full text

FIRST RESULTS OF CHD PROGNOSIS STUDY by E. A. Gofman, S. Yu. Martsevich, A. D. Deev, A. M. Malysheva, Yu. N. Polyanskaya, S. N. Tolpygina, V. P. Mazaev

Get full text

Epidemiological networks and drug resistance of HIV type 1 in Krasnoyarsk region, Russia by Rumyantseva, Olga A, Olkhovskiy, Igor A, Malysheva, Marina A, Ruzaeva, Ludmila A, Vasiliev, Alexander V, Kazennova, Elena V, Bobkova, Marina R, Lukashov, Vladimir V

“…To study the molecular epidemiology of HIV-1 in Krasnoyarsk region, Russia, where HIV-1 has spread rapidly since 2000, we obtained pol sequences from…”
Get more information

Clinical and epidemiological aspects of influenza chemoprophylaxis with bonaphthone by Zykov, M P, Zlydnikov, D M, Romanov, Iu A, Shvetsova, E G, Malysheva, A M

“…The results of double blind clinical, phisiological, biochemical immunological and virological studies carried out in 460 normal volunteers gave sufficiently…”
Get more information

Evaluation of the effectiveness of amantadine in various respiratory infections based on the results of a serological study by Taros, L Iu, Malysheva, A M

Get more information